The global oncology molecular diagnostic market size is accounted at USD 3.06 billion in 2025 and is forecasted to hit around USD 8.50 billion by 2034, representing a CAGR of 11.99% from 2025 to 2034. The North America market size was estimated at USD 1.12 billion in 2024 and is expanding at a CAGR of 12.04% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Oncology Molecular Diagnostic Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Oncology Molecular Diagnostic Market Revenue and Volume, by Type
8.1.1 Breast Cancer
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Prostate Cancer
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Colorectal Cancer
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Cervical Cancer
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Liver Cancer
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Lung Cancer
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Lung Cancer
8.1.7.1. Market Revenue and Volume Forecast
8.1.8. Blood Cancer
8.1.8.1. Market Revenue and Volume Forecast
8.1.9. Kidney Cancer
8.1.9.1. Market Revenue and Volume Forecast
8.1.10. Other Cancer
8.1.10.1. Market Revenue and Volume Forecast
9.1. Oncology Molecular Diagnostic Market Revenue and Volume, by February
9.1.1. Cathode
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Anode
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Electrolyte
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Separator
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Volume Forecast
10.1. Oncology Molecular Diagnostic Market Revenue and Volume, by March
10.1.1. Consumer
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Automotive
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Industrial
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Cheese
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type
11.1.2. Market Revenue and Volume Forecast, by February
11.1.3. Market Revenue and Volume Forecast, by March
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type
11.1.4.2. Market Revenue and Volume Forecast, by February
11.1.4.3. Market Revenue and Volume Forecast, by March
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type
11.1.5.2. Market Revenue and Volume Forecast, by February
11.1.5.3. Market Revenue and Volume Forecast, by March
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type
11.2.2. Market Revenue and Volume Forecast, by February
11.2.3. Market Revenue and Volume Forecast, by March
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type
11.2.4.2. Market Revenue and Volume Forecast, by February
11.2.4.3. Market Revenue and Volume Forecast, by March
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type
11.2.5.2. Market Revenue and Volume Forecast, by February
11.2.5.3. Market Revenue and Volume Forecast, by March
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type
11.2.6.2. Market Revenue and Volume Forecast, by February
11.2.6.3. Market Revenue and Volume Forecast, by March
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type
11.2.7.2. Market Revenue and Volume Forecast, by February
11.2.7.3. Market Revenue and Volume Forecast, by March
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type
11.3.2. Market Revenue and Volume Forecast, by February
11.3.3. Market Revenue and Volume Forecast, by March
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type
11.3.4.2. Market Revenue and Volume Forecast, by February
11.3.4.3. Market Revenue and Volume Forecast, by March
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type
11.3.5.2. Market Revenue and Volume Forecast, by February
11.3.5.3. Market Revenue and Volume Forecast, by March
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type
11.3.6.2. Market Revenue and Volume Forecast, by February
11.3.6.3. Market Revenue and Volume Forecast, by March
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type
11.3.7.2. Market Revenue and Volume Forecast, by February
11.3.7.3. Market Revenue and Volume Forecast, by March
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type
11.4.2. Market Revenue and Volume Forecast, by February
11.4.3. Market Revenue and Volume Forecast, by March
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type
11.4.4.2. Market Revenue and Volume Forecast, by February
11.4.4.3. Market Revenue and Volume Forecast, by March
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type
11.4.5.2. Market Revenue and Volume Forecast, by February
11.4.5.3. Market Revenue and Volume Forecast, by March
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type
11.4.6.2. Market Revenue and Volume Forecast, by February
11.4.6.3. Market Revenue and Volume Forecast, by March
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type
11.4.7.2. Market Revenue and Volume Forecast, by February
11.4.7.3. Market Revenue and Volume Forecast, by March
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type
11.5.2. Market Revenue and Volume Forecast, by February
11.5.3. Market Revenue and Volume Forecast, by March
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type
11.5.4.2. Market Revenue and Volume Forecast, by February
11.5.4.3. Market Revenue and Volume Forecast, by March
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type
11.5.5.2. Market Revenue and Volume Forecast, by February
11.5.5.3. Market Revenue and Volume Forecast, by March
12.1. Roche Diagnostics
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Abbott Laboratories
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Thermo Fisher Scientific Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Illumina, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Qiagen N.V.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Bio-Rad Laboratories, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Genomic Health, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Myriad Genetics, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Agilent Technologies, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Siemens Healthineers
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample